At a glance
- Originator Unknown
- Developer Bioprojet; Nonindustrial source
- Class Amino acids; Antihypertensives; Dioxoles; Small molecules
- Mechanism of Action ACE inhibitors; Endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 28 Feb 1995 Discontinued-Unspecifed for Hypertension in France (Unknown route)